Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -88.41 |
| peg ratio | -2.01 |
| price to book ratio | 39.71 |
| price to sales ratio | -75,058.22 |
| enterprise value multiple | -95.79 |
| price fair value | 39.71 |
profitability ratios | |
|---|---|
| gross profit margin | 385.96% |
| operating profit margin | 77226.38% |
| pretax profit margin | 83760.85% |
| net profit margin | 83693.19% |
| return on assets | -39.11% |
| return on equity | -104.22% |
| return on capital employed | -40.89% |
liquidity ratio | |
|---|---|
| current ratio | 8.31 |
| quick ratio | 8.31 |
| cash ratio | 1.59 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | -1,025.11 |
| days of payables outstanding | 1,766.34 |
| cash conversion cycle | -2,791.45 |
| receivables turnover | -0.36 |
| payables turnover | 0.21 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.06 |
| debt equity ratio | 0.07 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.07 |
| interest coverage | -15.68 |
| cash flow to debt ratio | -3.47 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.16 |
| cash per share | 0.67 |
| operating cash flow per share | -0.16 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.47 |
| short term coverage ratios | -4.61 |
| capital expenditure coverage ratio | -890.05 |
Frequently Asked Questions
Summit Therapeutics Inc. (SMMT) published its most recent earnings results on 30-10-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Summit Therapeutics Inc. (NASDAQ:SMMT)'s trailing twelve months ROE is -104.22%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Summit Therapeutics Inc. (SMMT) currently has a ROA of -39.11%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
SMMT reported a profit margin of 83693.19% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.31 in the most recent quarter. The quick ratio stood at 8.31, with a Debt/Eq ratio of 0.07.